Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-02-03

Clinical Trial Update: Human Chorionic Gonadotrophin in an Antagonist Protocol [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2/Phase 3 study evaluating human chorionic gonadotropin used in an antagonist protocol for infertil…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Human Chorionic Gonadotrophin (human chorionic gonadotropin)

Snippet

Sponsor: Cairo University | Conditions: Infertility | Phase 2, Phase 3 | Status: COMPLETED